Vol.

No.

July 01, 2022Jul 01, 2022

Free

DOWNLOAD THE PDF

“This is not about protecting life”: Supreme Court overturn of Roe v. Wade threatens lives of cancer patients, doctors

Cover Story

Free

“This is not about protecting life”: Supreme Court overturn of Roe v. Wade threatens lives of cancer patients, doctors

By Alexandria Carolan and Alice Tracey

When Jill Hawkins realized that she was six weeks pregnant this March, her oncologist gave her two options.

Conversation with The Cancer Letter Free

Harvard Law’s I. Glenn Cohen: To provide good care, doctors will run afoul of criminal law in some states as Roe v. Wade ends

By Matthew Bin Han Ong

Free Guest Editorial

Cancer patients and their families will feel the impact of SCOTUS abortion ruling

By Karen E. Knudsen

Free Guest Editorial

Cancer care must remain in the hands of doctors and their patients

By Julie R. Gralow

Free Guest Editorial

Virginia gynecologic oncologists: “Pro-life” is not pro-life at all

By Leslie M. Randall, Devin T. Miller and Stephanie A. Sullivan

Free

Oncology and healthcare groups respond to the end of Roe v. Wade

In Brief

Selwyn M. Vickers named MSK president and CEO

Alicia M. Terando named San Gabriel Valley regional medical director for surgical oncology at Cedars-Sinai

Colleen Lewis named vice president of nursing and research at Florida Cancer Specialists and Research Institute

Justin F. Klamerus named EVP, chief medical officer at McLaren Health Care

Jeffrey M. Rosen to receive 2022 William L. McGuire Memorial Lecture Award

ASTRO announces 2022 Fellows

ACCC supports CMS Enhancing Oncology Model but says it may disadvantage small practices

Clinical Roundup

OSUCCC – James study identifies molecular factors driving melanoma development

SWOG-nCartes pilot collaboration shows significant expected time savings for study data entry

Drugs & Targets

FDA approves Breyanzi in relapsed or refractory large B-cell lymphoma after one prior therapy

EMA CHMP adopts positive opinion for Lynparza in germline BRCA-mutated, HER2-negative high-risk early breast cancer

Community Health Network, GRAIL to offer Galleri MCED test in Central Indiana

FDA issues draft guidance on patient-focused drug development

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 44 - November 22, 2024

“This is not about protecting life”: Supreme Court overturn of Roe v. Wade threatens lives of cancer patients, doctors

Harvard Law’s I. Glenn Cohen: To provide good care, doctors will run afoul of criminal law in some states as Roe v. Wade ends

Cancer patients and their families will feel the impact of SCOTUS abortion ruling

Cancer care must remain in the hands of doctors and their patients

Virginia gynecologic oncologists: “Pro-life” is not pro-life at all

Oncology and healthcare groups respond to the end of Roe v. Wade

In Brief

Selwyn M. Vickers named MSK president and CEO

Alicia M. Terando named San Gabriel Valley regional medical director for surgical oncology at Cedars-Sinai

Colleen Lewis named vice president of nursing and research at Florida Cancer Specialists and Research Institute

Justin F. Klamerus named EVP, chief medical officer at McLaren Health Care

Jeffrey M. Rosen to receive 2022 William L. McGuire Memorial Lecture Award

ASTRO announces 2022 Fellows

ACCC supports CMS Enhancing Oncology Model but says it may disadvantage small practices

Clinical Roundup

OSUCCC – James study identifies molecular factors driving melanoma development

SWOG-nCartes pilot collaboration shows significant expected time savings for study data entry

Drugs & Targets

FDA approves Breyanzi in relapsed or refractory large B-cell lymphoma after one prior therapy

EMA CHMP adopts positive opinion for Lynparza in germline BRCA-mutated, HER2-negative high-risk early breast cancer

Community Health Network, GRAIL to offer Galleri MCED test in Central Indiana

FDA issues draft guidance on patient-focused drug development

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login